Citadel Advisors - YUMANITY THERAPEUTICS INC ownership

YUMANITY THERAPEUTICS INC's ticker is YMTX and the CUSIP is 98872L102. A total of 26 filers reported holding YUMANITY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of YUMANITY THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$78,000
-60.2%
49,543
-54.1%
0.00%
Q2 2022$196,000
-15.5%
107,979
-30.0%
0.00%
Q1 2022$232,000
+95.0%
154,300
+284.1%
0.00%
Q4 2021$119,000
-27.4%
40,172
+152.7%
0.00%
Q3 2021$164,000
+281.4%
15,900
-66.4%
0.00%
Q1 2021$43,00047,3810.00%
Other shareholders
YUMANITY THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 108,847$1,850,0001.42%
SPHERA FUNDS MANAGEMENT LTD. 130,434$2,217,0000.20%
HARBOURVEST PARTNERS LLC 22,030$375,0000.15%
Redmile Group, LLC 611,003$10,387,0000.13%
Ikarian Capital, LLC 132,514$2,253,0000.10%
Artal Group S.A. 217,391$3,696,0000.08%
Maven Securities LTD 43,478$739,0000.07%
Bain Capital Public Equity Management II, LLC 31,331$533,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 14,498$246,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11,000$187,0000.00%
View complete list of YUMANITY THERAPEUTICS INC shareholders